+
CMRL Targets March 2027 Opening for Vadapalani–Panagal Park
RAILWAYS & METRO RAIL

CMRL Targets March 2027 Opening for Vadapalani–Panagal Park

Chennai Metro Rail Limited (CMRL) is progressing as scheduled to open the Vadapalani–Panagal Park section of Phase II’s Corridor 4 by March 2027. The 3.5 km underground stretch is part of the 26.1 km Corridor 4 connecting Lighthouse with Poonamallee Bypass.

Construction activities are advancing steadily, with tunnelling works between Vadapalani and Panagal Park already completed. Track-laying operations are expected to commence shortly. At Panagal Park station, structural works have reached the concourse and platform levels, while excavation continues at the lowest level.

CMRL is also considering opening another segment of Corridor 4, between Poonamallee and Vadapalani, as the first operational Phase II line, potentially as early as February.

Once commissioned, the Vadapalani–Panagal Park section will provide direct metro connectivity to T Nagar. Passengers will be able to use the existing Phase I network and interchange at Vadapalani, significantly reducing travel time. Panagal Park station will also serve a key operational function, being one of two major stations on Corridor 4 equipped with crossover tracks for depot access and emergency operations.


Chennai Metro Rail Limited (CMRL) is progressing as scheduled to open the Vadapalani–Panagal Park section of Phase II’s Corridor 4 by March 2027. The 3.5 km underground stretch is part of the 26.1 km Corridor 4 connecting Lighthouse with Poonamallee Bypass.Construction activities are advancing steadily, with tunnelling works between Vadapalani and Panagal Park already completed. Track-laying operations are expected to commence shortly. At Panagal Park station, structural works have reached the concourse and platform levels, while excavation continues at the lowest level.CMRL is also considering opening another segment of Corridor 4, between Poonamallee and Vadapalani, as the first operational Phase II line, potentially as early as February.Once commissioned, the Vadapalani–Panagal Park section will provide direct metro connectivity to T Nagar. Passengers will be able to use the existing Phase I network and interchange at Vadapalani, significantly reducing travel time. Panagal Park station will also serve a key operational function, being one of two major stations on Corridor 4 equipped with crossover tracks for depot access and emergency operations.

Next Story
Real Estate

Heritage Reimagined

At Darabshaw House in Ballard Estate, The House of Rose represents more than a retail flagship. It is an architectural negotiation between legacy and contemporary restraint—where business ambition and spatial discipline converge.Framing the intent, Biren Vaidya, Managing Director, The Rose Group of Companies, says, “It has always been a dream, nurtured over the last forty-five years, to create a luxury brand of Indian origin with true international standing.” He adds, “With the current generation, luxury has become quieter, more personal, and deeply experiential.” ..

Next Story
Infrastructure Energy

Numaligarh Refinery Expansion Cost Rises to Rs 340 Billion

Numaligarh Refinery Limited has revised the cost estimate for its expansion project to Rs 340 billion (bn) and has sought government approval for the higher budget. The company indicated that the revised figure supersedes earlier estimates and will alter the capital requirements for the scheme. The expansion is intended to increase processing capacity and modernise facilities, subject to regulatory clearance. Officials said the request was submitted to federal authorities for consideration and clearance. The revision reflects an upward adjustment driven by increased capital outlay, higher comm..

Next Story
Infrastructure Urban

Cytiva Expands Fast Trak Facility in Bengaluru

Cytiva, a Danaher company, has expanded its Fast Trak process development (PD) and validation services facility in Bengaluru, strengthening India’s position in the global biopharma landscape. The newly inaugurated ~30,000 sq ft centre brings upstream and downstream process development, optimisation, scale-up and validation services under one roof. The facility is designed to support multiple modalities including monoclonal antibodies (mAbs), pDNA/mRNA, recombinant proteins and viral vectors. It aims to help biopharma companies across India and Asia-Pacific shorten development timelines, red..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Open In App